Steric inhibition of human immunodeficiency virus type-1 Tat-dependent trans-activation in vitro and in cells by oligonucleotides containing 2′-O-methyl G-clamp ribonucleoside analogues

Nucleic Acids Research

Volumn 31, Issue 11, 2003, Pages 2759-2768

  Holmes, Stephen C ^a   Arzumanov, Andrey A ^a   Gait, Michael J ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; OLIGONUCLEOTIDE; PHOSPHORAMIDIC ACID DERIVATIVE; RIBONUCLEOSIDE DERIVATIVE; TRANSACTIVATOR PROTEIN; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DNA; OLIGORIBONUCLEOTIDE; ORGANOPHOSPHORUS COMPOUND; PHOSPHORAMIDOUS ACID; RIBONUCLEOSIDE;

ARTICLE; BINDING AFFINITY; CHIMERA; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RNA BINDING; STEREOCHEMISTRY; SYNTHESIS; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS ACTIVATION; VIRUS INHIBITION; BINDING SITE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HELA CELL; METABOLISM; METHYLATION; NUCLEOTIDE SEQUENCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

ANTI-HIV AGENTS; BASE SEQUENCE; BINDING SITES; DNA; GENE PRODUCTS, TAT; HELA CELLS; HIV-1; HUMANS; METHYLATION; OLIGORIBONUCLEOTIDES; ORGANOPHOSPHORUS COMPOUNDS; RIBONUCLEOSIDES; RNA, VIRAL; TRANS-ACTIVATION (GENETICS);

EID: 0038268062     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg384     Document Type: Article

References (44)

1. Toulmé,J.J. (2001) New candidates for true antisense. Nat. Biotechnol., 19, 17-18.
2. Baker,B.F., Lot,S.S., Condon,T.P., Cheng-Flourney,S., Lesnik,E.A., Sasmor,H.M. and Bennett,C.F. (1997) 2′-O-(2-methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol. Chem., 272, 11994-12000.
3. Dias,N., Dheur,S., Nielsen,P.E., Gryaznov,S., Van Aerschot,A., Herdewijn,P., Hélène,C. and Saison-Behmoaras,T.E. (1999) Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation. J. Mol. Biol., 294, 403-416.
4. Faria,M., Spiller,D.G., Dubertret,C., Nelson,J.S., White,M.R.H., Scherman,D., Hélène,C. and Giovannangeli,C. (2001) Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo. Nat. Biotechnol., 19, 40-44.
5. Mercatante,D.R. and Kole,R. (2002) Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression. Biochim. Biophys Acta, 1587, 126-132.
6. Vickers,T.A., Wyatt,J.R., Burckin,T., Bennett,C.F. and Freier,S.M. (2001) Fully modified 2′-MOE oligonucleotides redirect polyadenylation. Nucleic Acids Res., 29, 1293-1299.
7. Monia,B.P., Lesnik,E.A., Gonzalez,C., Lima,W.F., McGee,D., Guinosso,C.J., Kawasaki,A.M., Cook,P.D. and Freier,S.M. (1993) Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem., 268, 14514-14522.
8. Mann,C.J., Honeyman,K., Cheng,A.J., Ly,T., Lloyd,F., Fletcher,S., Morgan,J.E., Partridge,T.A. and Wilton,S.D. (2001) Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc. Natl Acad. Sci. USA, 98, 42-47.
9. Schmitz,J.C., Yu,D., Agrawal,S. and Chu,E. (2001) Effect of 2′-O-methyl antisense ORNs on expression of thymidylate synthase in human colon cancer RKO cells. Nucleic Acids Res., 29, 415-422.
10. Schmajuk,G., Sierakowska,H. and Kole,R. (1999) Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake. J. Biol. Chem., 274, 21783-21789.
11. Giles,R.V., Spiller,D.G., Clark,R.E. and Tidd,D.M. (1999) Antisense morpholino oligonucleotide analog induces missplicing of C-myc mRNA. Antisense Nucleic Acid Drug Dev., 9, 213-220.
12. Doyle,D.F., Braasch,D.A., Simmons,C.G., Janowski,B.A. and Corey,D.R. (2001) Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases and PNA length. Biochemistry, 40, 53-64.
13. Karras,J.G., Maier,M.A., Watt,A. and Manoharan,M. (2001) Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-α chain. Biochemistry, 40, 7853-7859.
14. Sazani,P., Kang,S.-H., Maier,M.A., Wei,C., Dillman,J., Summerton,J., Manoharan,M. and Kole,R. (2001) Nuclear antisense effects of neutral, anionic and cationic analogs. Nucleic Acids Res., 29, 3965-3974.
15. Karn,J. (1999) Tackling Tat. J. Mol. Biol., 293, 235-254.
16. Taube,R., Fujinaga,K., Wimmer,J., Barboric,M. and Peterlin,B.M. (1999) Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology, 264, 245-253.
17. Rana,T.M. and Jeang,K.-T. (1999) Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Arch. Biochem. Biophys., 365, 175-185.
18. Dingwall,C., Ernberg,I., Gait,M.J., Green,S.M., Heaphy,S., Karn,J., Lowe,A.D., Singh,M. and Skinner,M.A. (1990) HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J., 9, 4145-4153.
19. Richter,S., Cao,H. and Rana,T.M. (2002) Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation. Biochemistry, 41, 6391-6397.
20. Wilson,W.D. and Li,K. (2000) Targeting RNA with small molecules. Curr. Med. Chem., 7, 73-98.
21. Mestre,B., Arzumanov,A., Singh,M., Boulmé,F., Litvak,S. and Gait,M.J. (1999) Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA. Biochim. Biophys Acta, 1445, 86-98.
22. Arzumanov,A. and Gait,M.J. (1999) Inhibition of the HIV-1 Tat protein-TAR RNA interaction by 2′-O-methyl oligoribonucleotides. In Holy,A. and Hocek,M. (eds), Collection Symposium Series. Academy of Sciences of the Czech Republic. Vol. 2, pp. 168-174.
23. Arzumanov,A., Walsh,A.P., Liu,X., Rajwanshi,V.K., Wengel,J. and Gait,M.J. (2000) XIV International Round Table. Nucleosides, Nucleotides and Their Biological Applications. International Medical Press, San Francisco.
24. Arzumanov,A., Walsh,A.P., Liu,X., Rajwanshi,V.K., Wengel,J. and Gait,M.J. (2001) Oligonucleotide analogue interference with the HIV-1 Tat protein-TAR RNA interaction. Nucl. Nucl., 20, 471-480.
25. Arzumanov,A., Walsh,A.P., Rajwanshi,V.K., Kumar,R., Wengel,J. and Gait,M.J. (2001) Inhibition of HIV-1 Tat-dependent trans-activation by steric block chimeric 2′-O-methyl/LNA oligoribonucleotides. Biochemistry, 40, 14645-14654.
26. Mayhood,T., Kaushik,N., Pandey,P.K., Kashanchi,F., Deng,L. and Pandey,V.N. (2000) Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to the TAR hairpin element. Biochemistry, 39, 11532-11539.
27. Kaushik,M.J., Basu,A. and Pandey,P.K. (2002) Inhibition of HIV-1 replication by anti-transactivation responsive polyamide nucleotide analog. Antiviral Res., 56, 13-27.
28. Kaushik,N., Basu,A., Palumbo,P., Nyers,R.L. and Pandey,V.N. (2002) Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type I production. J. Virol., 76, 3881-3891.
29. Froehler,B.C., Wadwani,S., Terhorst,T.J. and Gerrard,S.R. (1992) Oligodeoxynucleotides containing C-5 propyne analogs of 2′-deoxyuridine and 2′-deoxycytidine. Tetrahedron Lett., 33, 5307-5310.
30. Koshkin,A.A., Singh,S.K., Nielsen,P., Rajwanshi,V.K., Kumar,R., Meldgaard,M., Olsen,C.E. and Wengel,J. (1998) LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation and unprecedented nucleic acid recognition. Tetrahedron, 54, 3607-3630.
31. Lin,K.-Y. and Matteucci,M. (1998) A cytosine analogue capable of clamp-like binding to a guanine in helical nucleic acids. J. Am. Chem. Soc., 120, 8531-8532.
32. Maier,M.A., Leeds,J.M., Balow,G., Springer,R.H., Bharadwaj,R. and Manoharan,M. (2002) Nuclease resistance of oligonucleotides containing the tricyclic cytosine analogues phenoxazine and 9-(2-aminoethoxy)-phenoxazine ('G-clamp') and origins of their nuclease resistance properties. Biochemistry, 41, 1323-1327.
33. Rajeev,K.G., Maier,M.A., Lesnik,E.A. and Manoharan,M. (2002) High-affinity peptide nucleic acid oligomers containing tricyclic cytosine analogues. Org. Lett., 4, 4395-4398.
34. Ausin,C., OrtegaJ.-A., Robles,J., Grandas,A. and Pedroso,E. (2002) Synthesis of amino- and guanidino-G-clamp PNA monomers. Org. Lett., 4, 4073-4075.
35. Brown,T. and Brown,D.J.S. (1991) Modern machine-aided methods of oligodeoxyribonucleotide synthesis. In Eckstein,F. (ed.), Oligonucleotides and Analogues: A Practical Approach. Oxford University Press, Oxford, pp. 1-24.
36. Rittner,K., Churcher,M.J., Gait,M.J. and Karn,J. (1995) The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription. J. Mol. Biol., 248, 562-580.
37. McGregor,C., Perrin,C., Monck,M., Camilleri,P. and Kirby,A.J. (2001) Rational approaches to the design of cationic gemini surfactants for gene delivery. J. Am. Chem. Soc., 26, 6215-6220.
38. Nyilas,A. and Chattopadhyaya,J. (1986) Synthesis of O2′-methyluridine, O2′-methylcytidine, N4,O2′-dimethylcytidine and N4,N4,02′-trimethylcytidine from a common intermediate. Acta Chem. Scand, 40, 826-830.
39. Reese,C.B., Titmas,R.C. and Yau,L. (1978) Oximate ion unblocking of oligonucleotide phosphotriester intermediates. Tetrahedron Lett., 19, 2727-2730.
40. Wai,J.S., Williams,T.M., Bamberger,D.L., Fisher,T.E., Hoffman,J.M., Hudcosky,R.J., Mactough,S.C., Rooney,C.S., Saari,W.S., Thomas,C.M. et al. (1993) Synthesis and evaluation of 2-pyridinone derivatives as specific HIV-1 reverse transcriptase inhibitors. 3. Pyridyl and phenyl analogs of 3-aminopyridin-2(1H)-one. J. Med. Chem., 36, 249-255.
41. Darfeuille,F., Arzumanov,A., Gait,M.J., Di Primo,C. and Toulmé,J.J. (2002) 2′-O-methyl RNA hairpins generate loop-loop complexes and selectively inhibit HIV-1 Tat-mediated transcription. Biochemistry, 41, 12186-12192.
42. Zhang,J., Tamilarisu,N., Hwang,S., Garber,M.E., Huq,I., Jones,K.A. and Rana,T.M. (2000) HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1. J. Biol. Chem., 275, 34314-34319.
43. Aupeix-Scheidler,K., Chabas,S., Bidou,L., Rousset,J.-P., Leng,M. and Toulmé,J.J. (2000) Inhibition of in vitro and ex vivo translation by a transplatin-modified oligo(2′-O-methylribonucleotide) directed against the HIV-1 gag-pol frameshift signal. Nucleic Acids Res., 28, 438-445.
44. Flanagan,W.M., Wagner,R.W., Grant,D., Lin,K.-Y. and Matteucci,M. (1999) Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide. Nat. Biotechnol., 17, 48-52.